The global autoimmune treatment market size is anticipated to register a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the wide prevalence of autoimmune diseases coupled with the increasing awareness among patients regarding the availability of several alternatives for the treatment of autoimmune diseases. Rising investments for the development of new therapeutics and drugs are expected to boost further market expansion.
When the immune system attacks the healthy cells in the body mistakenly it is known as autoimmune disease. They attack parts such as joints or skin by releasing antibodies that attack the healthy cells. In some cases, only one organ gets attacked by autoimmune diseases whereas in other cases the whole body gets affected by autoimmune diseases. It is not possible to cure the autoimmune disease permanently; however, the intense response by the immune system can be treated and controlled by reducing the inflammation and pain.
The market is expected to grow due to increasing cases of autoimmune diseases. As per the statistics reported by the National Institute of Health (NIH), in the US alone, approximately 23.5 individuals are suffering from autoimmune diseases. Another report by RheumatoidArthritis.org suggests that about 1.3 million Americans are suffering from rheumatoid arthritis and the cases are increasing every year at a rapid pace.
The report on the global autoimmune treatment market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Autoimmune Treatment Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Applications (Systemic Autoimmune Diseases [Psoriasis, Rheumatoid Arthritis, Lupus, and Others] and Localized Autoimmune Diseases [Multiple Sclerosis]) and Products (Drugs, Diagnostic Equipment, and Therapeutic & Monitoring Equipment) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Bristol-Myers Squibb Co.; Amgen; Eli Lilly & Co.; Johnson & Johnson; Pfizer; AstraZeneca PLC; Roche; and Abbott Laboratories |
On the basis of applications, the global autoimmune treatment market is bifurcated into systemic autoimmune diseases and localized autoimmune diseases. The systemic autoimmune diseases segment is further divided into psoriasis, rheumatoid arthritis, lupus, and others while the localized autoimmune diseases segment consists of multiple sclerosis. The systemic autoimmune diseases segment is anticipated to dominate the market in the coming years owing to the increasing incidence of rheumatoid arthritis and increasing awareness level among the patients.
Based on products, the market is divided into drugs, diagnostic equipment, and therapeutic & monitoring equipment. The drugs segment is expected to expand at a substantial rate during the forecast period attributed to the fact that all the autoimmune diseases have chronic nature cannot be cured permanently and require treatment with drugs. Some of the most commonly used drugs include hydroxychloroquine, glucocorticoids, anthralin, methotrexate, avonex, and non-steroidal anti-inflammatory drugs.
In terms of regions, the global autoimmune treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2019 and is projected to hold a major market share in the coming years due to the presence of a high population base being affected with autoimmune diseases along with the presence of high disposable income in the region. However, the market of Asia Pacific is estimated to exhibit considerable growth during the forecast period attributed to the improvement of healthcare infrastructure at a rapid pace coupled with the growing level of awareness among the patients related to the early diagnosis & treatment of autoimmune diseases.
The global autoimmune treatment market has been segmented on the basis of
Key players competing in the global autoimmune treatment market are Bristol-Myers Squibb Co.; Amgen; Eli Lilly & Co.; Johnson & Johnson; Pfizer; AstraZeneca PLC; Roche; and Abbott Laboratories. Many of these players have adopted business strategies such as development of novel drugs, launch of new products, advancement of technologies, partnerships, mergers, and production capacity expansion in order to increase their expansion, their consumer base, and market position globally.
Some other reports from this category!